Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson's disease patients.

Circadian rhythm Dysphagia Excessive daytime sleepiness Non-motor symptoms Parkinson progression marker initiative (PPMI) REM sleep behavior disorder

Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Mar 2020
Historique:
received: 07 09 2019
revised: 14 11 2019
accepted: 10 12 2019
pubmed: 25 12 2019
medline: 15 5 2021
entrez: 25 12 2019
Statut: ppublish

Résumé

The aim of the present study was to investigate the potential predictors of subjectively reported swallowing impairment in a cohort of early-stage and drug naïve Parkinson's disease patients. A retrospective analysis of the Parkinson Progression Markers Initiative (PPMI) data was conducted. PD patients with score ≥ 1 on MDS-UPDRS "item 2.3" and on SCOPA-AUT "question 1" were classified as "dysphagic" and were compared with "non-dysphagic" patients at baseline. After excluding baseline dysphagic subjects, we assessed the predictors of the development of dysphagia in the third year of follow-up. The baseline prevalence of dysphagia in PD was 10.4%, growing as high as 19.1% within year 3. Compared to PD subjects not complaining swallowing difficulties, dysphagic patients had significantly higher scores on REM sleep behavior questionnaire, Epworth sleepiness scale (ESS), geriatric depression scale and MDS-UPDRS I (p < .01), significantly lower caudate [ Early-stage PD patients often report swallowing difficulties. We found a close relationship between excessive daytime sleepiness and the development of swallowing impairment over three years of follow-up of de novo patients.

Identifiants

pubmed: 31874415
pii: S0022-510X(19)32391-3
doi: 10.1016/j.jns.2019.116626
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116626

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors declare no conflict of interests.

Auteurs

Massimo Marano (M)

Neurology, Neurophysiology and Neurobiology unit, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy. Electronic address: m.marano@unicampus.it.

Deepak Gupta (D)

Binter Center for Parkinson's Disease and Movement Disorders, University of Vermont Medical Center, Burlington, VT, USA.

Francesco Motolese (F)

Neurology, Neurophysiology and Neurobiology unit, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.

Mariagrazia Rossi (M)

Neurology, Neurophysiology and Neurobiology unit, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.

Vitaliana Luccarelli (V)

Otolaryngology unit, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.

Claudia Altamura (C)

Headache and Neurosonology unit, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.

Vincenzo Di Lazzaro (V)

Neurology, Neurophysiology and Neurobiology unit, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH